PIWORLD interview: John Rosier’s portfolio update July 2021
Jul 16th, 2021 by piworld
John shares his portfolio performance during the first 6 months of 2021, the main contributors and detractors. We get an update on De La Rue, his 2021 PIWORLD pick in December and what he's most bullish about today. We touch on his fund portfolio launched July 2020. John was very prescient in calling the markets during the Covid crash, so we ask his views on the outlook for markets and inflation.
00:55 John’s performance to date
02:36 Which stocks have been the best contributor to John’s performance? SDI (SDI)
05:39 Sigmaroc (SRC), before the Nordkalk Oy Ab reverse takeover announcement!
07:39 Sylvania Platinum (SLP)
11:05 K3 Capital (K3C)
12:14 Main detractors from John’s performance: Biotech Growth (BIOG), Baillie Gifford (BGUK), Syncona (SYNC) & Bioventix (BVXP)
16:09 De La Rue (DLAR)
23:40 Lundin Energy (LUNE)
32:23 Supreme (SUP)
36:28 John’s funds portfolio performance
40:39 Inflation and the market outlook
About John Rosier
In June 1984, John left university with a degree in Zoology and started work in The City of London. He enjoyed the first 14 years of his career at Fleming Investment Management, initially as an analyst and then as a UK portfolio manager; in 1997 he was appointed Head of UK Equities. He was a director at Henderson Global Investors from 1998 until 2004, before moving to the West End and working for two hedge funds. John’s investment career at Flemings and Henderson was focused on managing UK equity portfolios for corporate and local authority final salary defined benefit pension schemes as well as the reserve fund for the NSPCC. During 2009 John left full-time employment since when he has been managing his own portfolio.
John can be found at https://www.jicuk.com/